Barnes J L, Hevey K A, Hastings R R, Bocanegra R A
Department of Medicine, University of Texas Health Science Center, San Antonio.
Lab Invest. 1994 Apr;70(4):460-7.
Mesangial cells migrate in response to platelet released products in vitro (Am J Pathol 1991;138:859). Cell migration, in addition to proliferation might play a role in cell remodeling during the course of proliferative glomerular disease.
In this study, we examined mesangial cell migration in vivo in a platelet-dependent model of proliferative glomerulonephritis induced by Habu snake venom. Mesangial cell migration was assessed by phenotypic identification and temporal location of mesangial cells within glomerular lesions in serial time studies from 8 to 48 hours after Habu snake venom. Autoradiography of [3H]thymidine incorporation into cells was employed to identify and temporally separate cell division and proliferation from cell motility and other related events.
Early (8-hour) lesions consisted of microaneurysms devoid of mesangial cells. By 24 hours, glomeruli showed mesangial cells at the margins of lesions adjacent to intact glomerular tufts, followed by the presence of clusters of cells at 30 and 36 hours. By 48 hours, most lesions were filled with proliferating mesangial cells. Cells containing [3H]thymidine were rarely observed until 30 hours, at which point they were found in advanced lesions. Marginating cells did not contain [3H]thymidine, suggesting that the location of these cells was not related to cell division but rather to migration. Platelet depletion eliminated platelets from lesions and substantially retarded mesangial cell migration into glomerular lesions indicating mesangial cell migration is, in part, dependent on platelets or their secretory products.
These studies show that mesangial cells can migrate in vivo and suggest that cell migration is an important early step in cell redistribution and remodeling during glomerular injury in this model of proliferative glomerulonephritis.
体外实验中,系膜细胞可对血小板释放产物产生迁移反应(《美国病理学杂志》1991年;138卷:859页)。细胞迁移,除了增殖之外,可能在增殖性肾小球疾病病程中的细胞重塑过程中发挥作用。
在本研究中,我们在由蝮蛇毒诱导的增殖性肾小球肾炎的血小板依赖性模型中,检测了体内系膜细胞的迁移情况。通过对蝮蛇毒注射后8至48小时的连续时间研究,根据系膜细胞在肾小球病变内的表型鉴定和时间定位来评估系膜细胞迁移。采用[3H]胸腺嘧啶核苷掺入细胞的放射自显影法,以识别并在时间上区分细胞分裂和增殖与细胞运动及其他相关事件。
早期(8小时)病变由无系膜细胞的微动脉瘤组成。到24小时时,肾小球在与完整肾小球丛相邻的病变边缘出现系膜细胞,随后在30和36小时出现细胞簇。到48小时时,大多数病变充满了增殖的系膜细胞。直到30小时才很少观察到含有[3H]胸腺嘧啶核苷的细胞,此时它们出现在晚期病变中。处于边缘的细胞不含[3H]胸腺嘧啶核苷,这表明这些细胞的位置与细胞分裂无关,而是与迁移有关。血小板耗竭使病变中无血小板,并显著延迟系膜细胞向肾小球病变的迁移,这表明系膜细胞迁移部分依赖于血小板或其分泌产物。
这些研究表明系膜细胞可在体内迁移,并提示在该增殖性肾小球肾炎模型中,细胞迁移是肾小球损伤期间细胞重新分布和重塑的重要早期步骤。